Visipaque (GE Healthcare Inc.)
Welcome to the PulseAid listing for the Visipaque drug offered from GE Healthcare Inc.. This Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | GE Healthcare Inc. |
NON-PROPRIETARY NAME: | Iodixanol |
SUBSTANCE NAME: | IODIXANOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |
ROUTE: | INTRAVASCULAR |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-03-01 |
END MARKETING DATE: | 0000-00-00 |
Visipaque HUMAN PRESCRIPTION DRUG Details:
Item Description | Visipaque from GE Healthcare Inc. |
LABELER NAME: | GE Healthcare Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 270(mg/mL) |
START MARKETING DATE: | 2009-03-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0407-2222_53130b10-9dc3-44a0-863d-1b773b126d2a |
PRODUCT NDC: | 0407-2222 |
APPLICATION NUMBER: | NDA020808 |
Other IODIXANOL Pharmaceutical Manufacturers / Labelers: